ArticleActa parasitologica2024
Assessing the Oxidative Stress Reducing Potential of Spilanthes filicaulis (Schumach & Thonn) Ethyl-Acetate Sub-fractions on Plasmodium berghei Infected Female Mice.
Article in Acta parasitologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeInfections by Plasmodium parasite actuate oxidative stress. As malaria parasite actions overwhelm host antioxidant defense by producing excessive reactive species during haemoglobin degradation. This study aimed to evaluate the oxidative status by considering the antioxidant level of ethyl-acetate sub-fractions of Spilanthes filicaulis (ESSF) extract on Plasmodium berghei NK-65 parasitized mice.
methodsSixty female mice weighing 20.0 ± 3.0 g were inoculated intraperitoneally with 0.2 mL of parasitized erythrocytes randomly selected into five groups of 12 mice, Groups I and II were orally administered with normal saline (10 mL/kg) and chloroquine (10 mg/kg) while, Groups III, IV and V were administered 250,500 and 750 mg/kg per day respectively of ESSF. Mice in each group were sacrificed on days 4 and 8 post treatment, thereafter blood and liver samples were collected and prepared using standard methods to obtain erythrocytes and liver homogenates. Malondialdehyde (MDA), a measure of lipid peroxidation, superoxide dismutase (SOD) and catalase (CAT) level was assessed in the erythrocyte and liver.
resultsAdministration of ESSF produced a significant (p < 0.05) decrease in the MDA concentration of the parasitized treated group when compared to parasitized untreated group on day 4. Concomitantly, a significant (p < 0.05) increase in SOD and CAT activity in the treated groups with a corresponding decrease in the untreated group on day 4. However, effects of this action were more pronounced on day 8 in both tissues.
conclusionThese findings suggest that ESSF might contribute to the protection of malaria infected mice against oxidative disruptions by improving antioxidant status.
Indexed as
Identifiers
39356427What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.